Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Yih-leong Chang Chong-Jen Yu |
| Publication date | July 12, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |